Transgenomic's Q4 Revenues Increase 7 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market yesterday that its fourth-quarter revenues rose 7 percent year over year, and the firm swung from a loss to a profit.

The Omaha, Neb.-based molecular diagnostics and pharmacogenomics firm brought in total revenues of $6.5 million for the three-month period ended Dec. 31, compared to $6.1 million for the fourth quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.